Joseph S. Dosch

Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer.

A. Rehemtulla, J. Sebolt-Leopold, Joseph S Dosch, 2015, Cancer research.

c-Met is a marker of pancreatic cancer stem cells and therapeutic target.

T. Welling, M. Pasca di Magliano, D. Simeone, 2011, Gastroenterology.

Pancreatic cancer stem cells.

D. Simeone, C. J. Lee, Joseph S. Dosch, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Examining the Role of Hedgehog Signaling in the Pancreatic Tumor Microenvironment.

Joseph S Dosch, Joseph S. Dosch, 2011 .

Cancer Stem Cells: Pancreatic Cancer

D. Simeone, C. J. Lee, Joseph S Dosch, 2009 .

Pancreatic Cancer and Hedgehog Pathway Signaling: New Insights

M. Pasca di Magliano, D. Simeone, Joseph S. Dosch, 2010, Pancreatology.

Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells

B. Ross, A. Rehemtulla, G. Luker, 2015, Molecular imaging.

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency

E. Hurt, E. Fearon, R. Hollingsworth, 2017, Oncotarget.

Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy That Cotargets MEK and CDK4/6

Ananda Sen, T. Welling, J. Sebolt-Leopold, 2015, Clinical Cancer Research.

Sensitivity of Kras-mutant Colorectal Cancers to Combination Therapy That Co-targets Mek and Cdk4/6

J. Sebolt-Leopold, J. Maust, Elizabeth K Ziemke, 2022 .